Luc Dirix

A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002–2010

Gerda Verheyden, Luc Verkinderen, P. V. van Dam, 2013, World Journal of Surgical Oncology.

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.

John M S Bartlett, Hein Putter, Cornelis J H van de Velde, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

Guy Jerusalem, Cristina Saura, J. Baselga, 2014, Clinical Cancer Research.

Genomic profiling of inflammatory breast cancer: a review.

Daniel Birnbaum, Pascal Finetti, François Bertucci, 2014, Breast.

Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer?

P. Dam, P. Vermeulen, L. Dirix, 2005, Current opinion in oncology.

Coping with toxicities of docetaxel (TaxotereTM)

Dirk Schrijvers, Stanley B. Kaye, J. Wanders, 1993 .

Correction to: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature, (2016), 534, 7605, (47-54), 10.1038/nature17676)

Ville Mustonen, Sung-Min Ahn, Stefania Tommasi, 2019 .

Genomic and expression analysis of microdissected inflammatory breast cancer

Randa El-Zein, Massimo Cristofanilli, Savitri Krishnamurthy, 2013, Breast Cancer Research and Treatment.

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Aleksandar Sekulic, Michael R Migden, Axel Hauschild, 2012, The New England journal of medicine.